H&P Industries Recalls Povidine Iodine Prep Pads
H&P Industries announced a voluntary recall of all lots of its povidine iodine prep pads, which are private labeled for many accounts.
Diagnosis & Disease Information
Phase 2b Study of ATX-101 for Submental Fat Reduction
Kythera Biopharmaceuticals presented additional efficacy data from a Phase 2b study evaluating ATX-101 for the reduction of submental fat.
Xerese Available for the Treatment of Cold Sores
Xerese (acyclovir/hydrocortisone cream) has been made available by Meda for the treatment of recurrent herpes simplex labialis (cold sores).
HylatopicPlus-Aurstat Kit available for atopic dermatitis
Onset Dermatologics has launched the HylatopicPlus-Aurstat Kit for the treatment of atopic dermatitis.
Phase 2 study of Amigal for the treatment of Fabry disease
Amicus Therapeutics announced initiation of its Phase 2 study of Amigal (migalastat hydrochloride) with enzyme replacement therapy (ERT) for the treatment of Fabry disease.
Phase 2b study of delafloxacin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
Rib-X Pharmaceuticals announced the initiation of a Phase 2b trial to evaluate delafloxacin for the treatment of acute bacterial skin and skin structure infections (ABSSSI), including infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
Phase 2b study of ATX-101 for the reduction of submental fat
Kythera Biopharmaceuticals announced that it has successfully completed a third Phase 2 study with ATX-101 for the reduction of submental (“under-the-chin”) fat.
Phase 2b study of AN2728 for the treatment of psoriasis
Anacor Pharmaceuticals announced that the first patient has been dosed in a Phase 2b trial of AN2728 for the treatment of psoriasis.
PanOxyl Acne Creamy Wash available soon
Stiefel has launched PanOxyl Acne Creamy Wash (benzoyl peroxide) for the treatment of acne vulgaris.
Phase 2 study of DSC127 for the treatment of diabetic foot ulcers
Derma Sciences announced positive results from its Phase 2 clinical trial with DSC127 in patients with diabetic foot ulcers.
